Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 35.62 and traded as low as GBX 32.70. Cambridge Cognition shares last traded at GBX 32.70, with a volume of 7,690 shares trading hands.
Cambridge Cognition Price Performance
The stock has a 50 day moving average of GBX 34.65 and a two-hundred day moving average of GBX 35.62. The stock has a market cap of £17.60 million, a PE ratio of -8.38 and a beta of 0.80. The company has a debt-to-equity ratio of 29.16, a quick ratio of 0.96 and a current ratio of 0.40.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Stories
- Five stocks we like better than Cambridge Cognition
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
